Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 424
Selected: 0
NCT IDTitle
NCT00424060Epothilone ZK-219477 in Treating Patients With Recurrent Glioblastoma
NCT01802814International Study for Treatment of Standard Risk Childhood Relapsed ALL 2010
NCT00389688Pemetrexed Disodium and Cisplatin Before or After Surgery in Treating Patients With Stage IB or Stage II Non-Small Cell Lung Cancer That Can be Removed by Surgery
NCT00003287Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer
NCT00017095Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer
NCT00002511Radiation Therapy Compared With No Further Treatment Following Surgery in Treating Patients With Prostate Cancer
NCT04065165Lanreotide Combined With Telotristat Ethyl or Placebo for the First-line Treatment in Patients With Advanced Well Differentiated Small Intestinal Neuroendocrine Tumours (siNET) With Highly-functioning Carcinoid Syndrome
NCT00004937Acridine Carboxamide in Treating Patients With Recurrent Glioblastoma Multiforme
NCT00086866Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery
NCT00003151Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma
NCT00498953Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx
NCT00005053Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer
NCT00002777Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer
NCT00003209Radiation Therapy With or Without Chemotherapy After Surgery in Treating Patients With Stage IB or Stage IIA Cervical Cancer
NCT00047112Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer
NCT05270044Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.
NCT00003772Quality-of-Life Assessment in Patients With Ovarian Cancer
NCT00689221Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter Status
NCT06783348Radiopharmaceutical Treatment of Advanced Kidney Cancer
NCT01597414Elderly Metastatic Breast Cancer: Pertuzumab-Herceptin vs Pertuzumab-Herceptin-Metronomic Chemotherapy, Followed by T-DM1
NCT00025298Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx
NCT01386398Vorinostat With or Without Bortezomib in Treating Patients With Refractory or Recurrent Stage IIB, Stage III, or Stage IV Cutaneous T-Cell Lymphoma
NCT00849082Radiation Therapy With or Without Goserelin and Cyproterone in Treating Patients With Prostate Cancer
NCT00045032Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer
NCT00091572Temozolomide Versus Dacarbazine in Stage IV Metastatic Melanoma (Study P03267)
NCT00003771Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer
NCT03437200Combination of Chemoradiation With Immunotherapy in Inoperable œsophageal Cancer
NCT00438737Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal Cancer
NCT03260712Pembrolizumab in Biliary Tract Cancer
NCT00182819Radiation Therapy or Temozolomide in Treating Patients With Gliomas
NCT00047125Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor
NCT03488810Apalutamide With Radiotherapy and Androgen Deprivation Therapy in Prostate Cancer
NCT01098656Lenalidomide Maintenance Post-debulking in Advanced CTCL
NCT04128072Anti-CCR4 Monoclonal Antibody (Mogamulizumab) and Total Skin Electron Beam Therapy (TSEB) in Patients With Stage IB-IIB Cutaneous T-Cell Lymphoma
NCT01924819Trial of Preoperative Therapy for Gastric and Esophagogastric Junction Adenocarcinoma
NCT00020839Temozolomide With or Without Radiation Therapy to the Brain in Treating Patients With Stage IV Melanoma That Is Metastatic to the Brain
NCT00085475Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma
NCT04740372Development of an International COVID-19 Specific Quality of Life Questionnaire, Phase III. The OSLO COVID-19 QLQ
NCT04995575Dissecting the Pathways of Therapy Resistance in Early Breast Cancer
NCT00014300Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme
NCT00021112Combination Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Stage IIIB Non-Small Cell Lung Cancer
NCT05512364Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
NCT00003304Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors
NCT00003758Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia
NCT01652261Very Early FDG-PET/CT-response Adapted Therapy for Advanced Hodgkin Lymphoma (H11)
NCT00005061Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Solid Tumors
NCT06978062Peri-operative Treatment of Resectable Gastroesophageal Cancer Using Bemarituzumab (BEMA) Plus Perioperative Treatment
NCT00005583Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer
NCT02194842Phase III Radium 223 mCRPC-PEACE III
NCT00002763High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma